Unusual Retroperitoneal Soft Tissue Sarcomas: Giant Masqueraderers
Main Article Content
Keywords
Retroperitoneum, Fibrosarcoma, Liposarcoma, Extraskeletal Ewing Sarcoma
Abstract
Soft tissue sarcomas (STS) in the retroperitoneum are rare and account for a small percentage of adult STS. The most common type is liposarcoma, while fibrosarcoma and extra skeletal Ewing sarcoma (EES) are rarer. Retroperitoneal fibrosarcoma’s are extremely uncommon. Diagnosis requires a comprehensive evaluation including clinical, radiological, histopathological, and immunohistochemical examinations to determine the specific subtype of STS in the retroperitoneum. A 76-year-old male presented with a large retroperitoneal tumor. Surgery successfully removed the tumor which was diagnosed as dedifferentiated liposarcoma based on microscopic analysis and positive vimentin and MDM2 markers. We also report a case of 69 yea rold male with a retroperitoneal mass that was ultimately diagnosed as adult fibrosarcoma after ruling out other possibilities. The third case was of 55-year-old female who presented with left lumbar pain, backache, and weight loss. Imaging revealed a retroperitoneal mass with hepatic metastasis. Histopathological examination and IHC analysis confirmed the diagnosis of extraskeletal Ewing sarcoma. The importance of accurate diagnosis through histopathological examination and immunohistochemical analysis is emphasized for effective management and prognosis.
References
2. Brennan MF. Management of Soft Tissue Sarcoma. 1 ed. New York, NY: Springer (2013). 380p.
3. Thomas JM. Retroperitoneal sarcoma. Br J Surg (2007) 94(9):1057–8.
4. Dalal KMM. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg (2006) 244(3):381–91.
5. Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press (2002).
6. Dei Tos AP. Liposarcomas: diagnostic pitfalls and new insights. Histopathology (2014) 64(1):38–52.
7. Fletcher CD, Bridge JA, Hogendoorn P, Mertens F. World Health Organization Classification of Tumours; Pathology and Genetics. Tumours of Soft Tissue and Bone. Lyon: IARC Press (2013).
8. Abboud A, Masrouha K, Saliba M, Haidar R, Saab R, Khoury N, Tawil A, Saghieh S. Extraskeletal Ewing sarcoma: Diagnosis, management and prognosis. Oncol Lett. 2021 May;21(5):354. doi: 10.3892/ol.2021.
9. Desai SS, Jambhekar NA. Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts. Indian J Orthop. 2010 Oct;44(4):363-8. doi: 10.4103/0019-5413.69304.
10. Wang J, Grignol VP, Gronchi A, Luo CH, Pollock RE, Tseng WW. Surgical management of retroperitoneal sarcoma and opportunities for global collaboration. Chin Clin Oncol. 2018 Aug 1;7(4):39.
11. Choi JH, Ro JY. Retroperitoneal sarcomas: an update on the diagnostic pathology approach. Diagnostics. 2020 Aug 27;10(9):642.
12. Schmitz E, Nessim C. Retroperitoneal sarcoma care in 2021. Cancers. 2022 Mar 2;14(5):1293.
13. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol (1979) 3(6):507–23.
14.Coindre JM, Pedeutour F, Aurias A. Well-differentiated and dedifferentiated liposarcomas. Virchows Arch (2010) 456(2):167–79.
15.Thway K, Jones R, Noujaim J, Zaidi S, Miah A, Fisher C. Dedifferentiated liposarcoma. Adv Anat Pathol 2016; 23:30–40.
16. Vijay A, Ram L. Retroperitoneal liposarcoma. Am J Clin Oncol 2015 ;38:213–9.
17. Binh M, Guillou L, Hostein I, Château M, Collin F, Aurias A, et al. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk. Am J Surg Pathol 2007; 31:1557–66.
18. Pollack SM, Redman MW, Baker KK, Wagner MJ, Schroeder BA, Loggers ET, Trieselmann K, Copeland VC, Zhang S, Black G, McDonnell S, Gregory J, Johnson R, Moore R, Jones RL, Cranmer LD. Assessment of Doxorubicin and Pembrolizumab in Patients with Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial. JAMA Oncol. 2020 Nov 01;6(11):1778-1782.
19.Choi Y, Yun MS, Lim SH, Lee J, Ahn JH, Kim YJ, Park KH, Park YS, Lim HY, An H, Suh DC, Kim YH. Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study. Cancer Res Treat. 2018 Jan;50(1):175-182.
20. Folpe AL. Fibrosarcoma: a review and update. Histopathology. 2014 Jan;64(1):12-25.
21. Augsburger D, Nelson PJ, Kalinski T, Udelnow A, Knösel T, Hofstetter M, Qin JW, Wang Y, Gupta AS, Bonifatius S, Li M, Bruns CJ, Zhao Y. Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets andstrategies. Oncotarget. 2017 Nov 28;8(61):104638-104653.
22. Mansfield S, Pollock R, Grignol V. Surgery for abdominal well-differentiated liposarcoma. Curr Treat Options Oncol 2018; 19:1.
23.Zindanci I, Zemheri E, Kavala M, Kocaturk E, Can B, Turkoglu Z, Ulucay V, Ozbulak O. Fibrosarcoma arising from a burn scar. Eur J Dermatol. 2011 Nov-Dec;21(6):996-7.
24. Mukherjee A, Ray JG, Bhattacharya S, Deb T. ’Ewing’s sarcoma of mandible: A case report and review of Indian literature contemporary clinical dentistry (2012);3(4):494-498
25. Nasri S, Aqamour R, Haddar L, Guerrouj I, Haddar K, Aichouni N, Kamaoui I, Skiker I. Extraskeletal Ewing sarcoma: A case report. Radiol Case Rep. 2022 Oct 6;17(12):4809-4813. doi: 10.1016/j.radcr.2022.09.048
26. Javery O, Krajewski K, O'Regan K, Kis B, Giardino A, Jagannathan J, Ramaiya NH. A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. AJR Am J Roentgenol. 2011 Dec;197(6):W1015-22. doi: 10.2214/AJR.11.6667.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.